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Beltsville MD 20705, USA
(Received 26 October 2012; Accepted 25 April 2013; First published online 19 July 2013)
This study was designed to determine whether methyl-b-cyclodextrin (MCD) can substitute for albumin in incubation medium for
neonatal swine adipose tissue explants, or whether MCD affects metabolism and cytokine expression. Subcutaneous adipose
tissue explants (1006 10 mg) were prepared from 21-day-old pigs. Explants were incubated in medium 199 supplemented with
25 mM HEPES, 1.0 nM insulin at 378C. The medium also contained bovine serum albumin (BSA) or MCD at 0%, 0.05%, 0.1%,
0.2% or 0.3%. Tissue explants were treated with these media for 1 h and then switched to the same basal incubation medium
containing 0.05% BSA. Explants were removed from basal medium at 2 or 8 h of incubation, and real-time PCR was performed to
assess expression of tumor necrosis a (TNF) and interleukin 6 (IL6), acetyl CoA carboxylase (ACAC) and fatty acid synthase
(FASN). Alternatively, rates of 14C-glucose oxidation and lipogenesis were monitored6 insulin (100 nM), following MCD
treatment. Incubation with BSA had minimal effects on gene expression or adipose tissue metabolism, only producing a doubling
in TNF mRNA abundance ( P, 0.01). Treatment with MCD increased TNF mRNA abundance by eightfold ( P, 0.009), whereas
IL6 gene expression increased a 100-fold ( P, 0.001) with a suppression in ACAC and FASN expression ( P, 0.01). This was
paralleled by MCD inhibition of insulin-stimulated glucose oxidation and lipogenesis ( P, 0.001). Addition of a TNF antibody to
the incubation medium alleviated this inhibition of insulin-stimulated glucose metabolism by ,30% ( P, 0.05).
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Implications
Albumin is included in the incubation medium for adipose
tissue for multiple reasons. However, albumin has recently
been demonstrated to alter cytokine expression by human and
rodent adipocytes. Cyclodextrins have been used as an alter-
native to albumin in vitro and in vivo. However, the present
study demonstrates that methyl-b-cyclodextrin is not suitable
as an albumin substitute, as it reduces insulin-sensitive glucose
metabolism through induction of tumor necrosis factor a.
Introduction
The role of adipose-derived cytokines has recently come to
the forefront because of their interactions with adipocyte
metabolism and adipose tissue function (Jacobi et al., 2004;
Rasouli and Kern, 2008). Research into the regulation of the
expression of these paracrine cytokines in vitro typically
requires the use of albumin in the medium to reduce lysis of
the adipocytes through interaction with glass or plastic
containers; to bind fatty acids released by the adipocytes,
and thus prevent a feedback inhibition of metabolism; to
function as a carrier for fatty acids to improve solubility; or to
bind various proteins introduced into the medium to prevent
those added proteins from binding to the vessel. Schlesinger
et al. (2006) demonstrated that albumin (or it contaminants)
can interact with the adipocyte to induce the expression of
adipose-derived cytokines (adipokines), which complicates
the analysis of adipokine regulation. Ruan et al. (2003)
reported that the process of adipocyte isolation (in the
presence of albumin) can alter adipokine expression within
adipose tissue. Therefore, alternatives to albumin may be
necessary because of albumin induction of cytokine expression,
which complicates analysis of adipocyte-derived cytokines.
b-cyclodextrin has been used to bind fatty acids during
the in vitro analysis of fatty acid oxidation (Kato et al.,
1993 and 1994) and this would suggest that it may serve
as a substitute for albumin in adipose tissue incubation.
* Mention of trade name, proprietary product or vendor does not constitute a
guarantee or warranty of the product by the U.S. Department of Agriculture or imply
its approval to the exclusion of other products or vendors that also may be suitable.
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Methyl-b-cyclodextrin (MCD) has been used to bind fatty
acids for in vivo infusion into growing swine (Wray-Cahen
et al., 2001) without the report of any deleterious effects
when used at a 20% concentration (w/v) in the infusate,
whereas various porcine and bovine albumins at 5%
concentration (w/v) induced anaphylactic responses when
infused into swine. The conclusion was that MCD may serve
as an alternative carrier for fatty acids during infusions in
swine. This implies that MCD did not induce cytokines during
the infusion and suggests that MCD could be an alternative
to albumin for inclusion in adipose incubations during the
analysis of cytokine gene expression.
However, Le Lay et al. (2001) demonstrated that MCD can
alter glucose metabolism and gene expression in rat adipo-
cytes. Incubation of isolated inguinal rat adipocytes with
1 mM MCD could reduce insulin-stimulated glucose oxida-
tion by,50%. They postulated that this was because of the
depletion of cholesterol from the plasma membrane by MCD
as supplementation of cholesterol to the MCD could pre-
clude the reduction in insulin-stimulated glucose oxidation.
However, cholesterol depletion also induces gene expression
within 3T3-L1 adipocytes (Le Lay et al., 2001). Incubation
of differentiated 3T3-L1 cells with compactin (an inhibitor of
sterol synthesis), and use of a lipoprotein-deficient serum
in the medium resulted in a 70% reduction in cholesterol
content of the 3T3-L1 adipocytes after 4 days. The mRNA
abundance of tumor necrosis factor a (TNF) and interleukin
6 (IL6) appeared to be increased approximately fivefold
and threefold after 4 days, although statistical analysis was
not performed.
The use of MCD as a substitute for albumin for in vitro
analysis of adipocyte function may be limited by the reported
actions of MCD to alter adipocyte metabolism and its
potential effect on the expression adipokines. The present
study was designed to determine whether MCD alters glucose
metabolism and adipokine gene expression in adipose tissue
explants from neonatal swine.
Methodology
Experimental design
The first experiment compared responses in adipokine gene
expression, following incubation with increasing concentra-
tions of bovine serum albumin (BSA) or MCD. Albumin
and MCD were used at 0 (control), 0.05%, 0.1%, 0.2% and
0.3% in the medium and prepared through serial dilution.
Subcutaneous adipose tissue explants (100 mg) derived
from 21-day-old pigs were incubated with these concentra-
tions of albumin or MCD for 1 h. All explants were then
rinsed and blotted with a subsequent transfer to a basal
medium containing 0.05% albumin for 2 or 8 h of incubation.
The adipose tissue explants were then collected for the
analysis of TNF and IL6 mRNA abundance, and subsequently
acetyl CoA carboxylase (ACAC) and fatty acid synthase
(FASN) gene expression.
The effect of MCD on adipose metabolism was examined
by measuring 14C-glucose oxidation and incorporation into
lipid according to methods previously described (Ramsay,
2003). Following 0.2% MCD or 0.2% BSA treatments for 1 h,
tissue explants were transferred to 25 ml Erlenmeyer flasks
with a medium containing 0.05% BSA6 100 nM insulin
and 14C-glucose. Glucose metabolism was then monitored
for 2 h with subsequent collection of 14CO2 and extraction of
14C- labeled lipids from the tissue explants. Alternatively,
MCD- and BSA-treated explants were placed in a basal
medium (medium 199, 25 mM HEPES, 10 mm glucose,
0.05% BSA, 1 nM insulin) for 6 h and then transferred to
Erlenmeyer flasks for a 2-h 14C-glucose incubation (a total of
8 h post-BSA/MCD treatment). This was to allow comparison
with our gene expression data from the 8-h incubations
described above.
The BSA selected for use in this experiment Sigma #9543
(low endotoxin, ,0.1 ng/mg; Sigma-Aldrich, St. Louis, MO,
USA) was selected because low-endotoxin BSA preparations
produce minimal adipokine responses in human adipocytes,
relative to other types of BSA preparations (Schlesinger
et al., 2006). The MCD was cell culture grade and also
purchased from Sigma-Aldrich (#C4555). The concentration
range selected was based on the data of Le Lay et al. (2002)
that demonstrated an,35% reduction in glucose oxidation
by isolated adipocytes with 0.05% MCD and a 50% reduction
with ,1.3% MCD (1.0 mM) treatment.
The adipokine genes selected for analysis were TNF
and IL6. This was based on preliminary experiments that
indicated that these two adipokines are the most highly
expressed by porcine adipose tissue and demonstrate the
largest response to incubation with MCD among a number
of cytokines and metabolic genes (data not presented).
Tumor necrosis factor a has been the most characterized of
all adipokines and has key regulatory roles in the expression
of a variety of proteins (Cawthorn and Sethi, 2008), whereas
IL6 is secreted by pig adipose tissue (Ajuwon and Spurlock,
2005) and cultures of pig adipocytes (Hausman et al., 2006).
Acetyl CoA carboxylase and FASN are key regulatory genes
in the pathway for lipogenesis (Lenhard, 2011), and thus
were selected as metabolic markers.
Tissue handling
Briefly, adipose tissue was dissected using sterile technique
from 21-day-old pigs (Yorkshire3 Landrace3 Poland China),
n5 3 to 4 per experiment, with different pigs used for each
experiment. Dorsal subcutaneous adipose tissue samples
from between the second and fourth thoracic vertebrae were
acquired, following euthanasia by pentobarbital sodium
injection (200 mg/kg BW), according to procedures approved
by the Institutional Area Animal Use and Care Committee.
Adipose tissue strips were placed in Hanks buffer (378C,
pH 7.4, Sigma-Aldrich, St. Louis, MO, USA) and were
then dissected clean of any extraneous muscle tissue and
further separated into 1 cm2 cubes. Adipose tissue explants
(1006 10 mg) were prepared by slicing these tissue cubes
with a Stadie–Riggs microtome in a laminar flow hood by
procedures previously described (Ramsay and Richards,
2004). Tissue slices were rinsed twice with fresh Hanks
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buffer (378C, pH 7.4), blotted free of excess liquid and
weighed. Tissue slices were then transferred to 12-well
tissue culture plates containing 1 ml of medium 199 with
25 mM Hepes, 1.0 nM insulin and 0% to 0.3% BSA or 0% to
0.3% MCD at pH 7.4. Triplicate tissue slices were incubated
with these media in a tissue culture incubator at 378C with
95% air/5% CO2 for 1 h. Porcine insulin (Sigma-Aldrich,
St. Louis, MO, USA) was solubilized in 0.001 N HCl. Individual
hormone aliquots were thawed for each day of use and diluted
in incubation medium to the appropriate concentration.
Following 1-h incubation with BSA or MCD, tissue
explants were rinsed three times with fresh medium 199
(378C), blotted and transferred to another 12-well tissue
culture plate containing a basal medium that comprised
medium 199, 25 mM HEPES, 1 nM insulin and 0.05% BSA.
Controls were placed in the same medium but without BSA.
Parallel cultures were incubated for either 2 or 8 h to eval-
uate the effects of MCD on gene expression. Following this
incubation period, tissue explants were rinsed three times
with medium 199 (378C), blotted and then frozen in liquid
nitrogen and stored at 2808C for later analysis of gene
expression.
Glucose metabolism
Incubation medium comprised Medium 199 and supple-
mented with 25 mM Hepes, 10 mM glucose, 0.05% BSA,
100 nM insulin and 0.5mCi D-[U-14C]- glucose/ml (Moravek
Biochemicals, Brea, CA, USA). This medium (2 ml) was
placed in 25 ml siliconized Erlenmeyer flasks. Following
addition of radiolabeled medium and explants, flasks were
gassed for 1 min with 95% air, 5% carbon dioxide and then
capped with rubber stoppers containing a center well.
Following 2 h of incubation, 0.5 ml 1 N H2SO4 was injected
into the medium to kill the metabolic activity of the tissue.
After 10 minutes, methylbenzythonium hydroxide (Sigma-
Aldrich, St. Louis, MO, USA) was injected into the center well
to permit capture of CO2 for the next 30 min. Center wells
were subsequently transferred to scintillation vials containing
10 ml of scintillation cocktail (Bio-safe II, Research Products
International Corp., Mount Prospect, IL, USA) for counting.
Tissue explants were removed with forceps, blotted and
transferred to screw capped tubes containing 5 ml of Dole’s
solution for lipid extraction by the method used by deCingolani
(1972). Incorporation of 14C into total lipid and fatty acids
was determined following saponification, according to
the methods of Azain and Martin (1983). Each metabolic
experiment was repeated three times using three different
animals and using triplicate explants/treatment for each pig.
Data were calculated as nmole glucose utilized/hour per
100 mg tissue, but were represented in the graphs as relative
to tissue incubated without BSA or MCD, a control whose
value was arbitrarily set to 1.0.
An additional experiment was conducted to assess
the potential role of TNF or IL6 secreted by the explants
during incubation on the metabolism of the adipose tissue.
Antibodies to porcine TNF (10mg/ml) or IL6 (2.5mg/ml)
were included in the basal and radioactive incubation media
during the 2- and 8-h incubations and compared with media
without the antibodies. The anti-pig mouse monoclonal
antibody to TNF and the anti-pig goat polyclonal antibody to
IL6 were purchased from R&D Systems (Minneapolis, MN,
USA). Antibody concentrations for use in the medium were
based on preliminary experiments to produce a maximal
response. Otherwise, the methodology was identical to that
described above for measuring glucose metabolism.
Real-time PCR analysis of gene expression
Total RNA was isolated using Qiagen RNeasy spin columns,
according to the manufacturer’s protocol (Qiagen, Valencia,
CA, USA). Integrity of RNA was assessed via agarose gel
electrophoresis and RNA concentration was determined
spectrophotometrically using A260 and A280 measurements.
All primer sets were designed to span an intron as
previously described and utilized for real-time PCR (Ramsay
and Azain, 2007; Ramsay and Caperna, 2009; Ramsay et al.,
2010). The following primers were used for generating
a 180-base amplicon corresponding to a portion of the
TNF coding sequence: 50-CCCCTCTGAAAAAGACACCA-30
(forward), 50-TCGAAGTGCAGTAGGCAGAA-30 (reverse). The
primers for IL6 were used to create a 215 base amplicon:
50-ATGGCAGAAAAAGACGGATG-30 (forward), 50-GTGGTGG
CTTTGTCTGGATT-30 (reverse). Acetyl CoA carboxylase primers
included a 50-CTCCAGGACAGCACAGATCA-30 (forward),
50-GCCGAAACATCTCTGGGATA-30 (reverse) to produce a
170-base amplicon, whereas a 210-base amplicon was pro-
duced with the following primers for fatty acid synthase:
5’-AACGTCCTGCTGAAGCCTAA-3’ (forward), 5’-CTCCTTG
GAACCGTCTGTGT-3’ (reverse). The 18S rRNA was used
as a relative standard for comparisons (QuantumRNATM
Universal 18S Internal Standard; Ambion, Inc., Austin, TX,
USA) in parallel reactions.
Thermal cycling and data acquisition were performed
with a Bio-Rad iCycler IQ system (Bio-Rad Laboratories Inc.,
Hercules, CA, USA). Reverse transcription (RT) and real-time
PCR analysis were performed in a two-tube assay as pre-
viously described (Ramsay and Caperna, 2009). RT was done
using a Superscript First-Strand Synthesis System for RT-PCR
kit (Invitrogen, Carlsbad, CA, USA). Master mix was made
containing random hexamers (50 ng/ml), 10 mM dNTP mix,
RNase-free H2O and RNA (1mg/ml). The RNA mix was
annealed at 658C for 5 min. A second master mix was prepared
with 10X RT buffer, 25 mM MgCl2, 0.1 mM dithiothreitol and
1.0ml RNaseOut. This second master mix was added to the
RNA mix and incubated at 258C for 2 min. Superscript II was
then added and incubated at 258C for 10 min, 428C for 50 min
and 708C for 15 min. An aliquot of RNase H (1.0ml) was then
added and incubated at 378C for 20 min.
Real-time PCR was carried out using the IQ sybr green
supermix kit (Bio-Rad Laboratories Inc., Hercules, CA, USA).
A 24ml reaction mix was made containing 12.5ml sybr
green supermix, 1.0ml forward primer (10mM), 1.0ml
reverse primer (10mM) and 9.5ml sterile water. This reaction
mix was added to each well, followed by 1.0ml RT product
(25ml total volume). Parameters for all reactions were as
Ramsay, Blomberg and Caperna
1692
follows: 1 cycle at 958C for 15 min (PCR activation), followed
by 30 cycles, 948C for 15 s, 588C for 30 s, 728C for 30 s, with a
final extension at 728C for 8 min.
Melting curve analysis was performed on all real-time PCR
reactions to confirm specificity and identity of the real-time
PCR products. A nontemplate control was run for every
assay. Specificity of real-time PCR products was further
confirmed by agarose gel electrophoresis.
Quantification of gene expression
At the end of the PCR, baseline and threshold crossing
values (CT) for all analyzed genes were calculated using the
BioRad software, and the CT values were exported to
Microsoft Excel for analysis. The relative expression of the
genes of interest, standardized against the amount of 18S
mRNA, was calculated using the DDCT method (Winer et al.,
1999; Livak and Schmittgen, 2001). Values were calculated
as the mean6 s.e.m. of duplicate determinations from
triplicate tissue samples derived from each of four individual
animals for each experiment. Data are expressed relative to
values determined for incubations without BSA or MCD, a
control whose value was arbitrarily set at 1.0.
Statistical analysis
Data were analyzed by analysis of variance using SigmaPlot
12 software (SPSS Science, Chicago, IL, USA) to test for the
effects of treatment with MCD v. albumin. Mean separation
was analyzed using Student–Newman–Keuls test. Means
were defined as being different at P, 0.05.
Results
Tumor necrosis factor a mRNA abundance was increased 2 h
after treatment with 0.3% BSA (P, 0.05; Figure 1a), but not
with lower concentrations of BSA (P. 0.05). However, incu-
bation with 0.05% MCD increased TNF by ,80% (P, 0.01)
relative to basal medium or 0.05% BSA, when measured 2 h
after exposure. The response by TNF gene expression to MCD
increased to a maximal eightfold with 0.2% MCD in the
treatment medium (P5 0.009). Performing an 8-h incubation
after BSA or MCD treatment before sample collection resulted
in no change in TNF mRNA abundance from the control
incubation without BSA or MCD (P5 0.423; Figure 1b).
Interleukin 6 mRNA abundance was unaffected by
treatment with BSA at 2 h following treatment (P. 0.05),
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Figure 1 Changes in mRNA abundance in response to different concentrations of albumin or MCD with time. Tissue explants (,100 mg) were exposed to 0%
(control), 0.05%, 0.1%, 0.2% or 0.3% albumin or MCD in medium 199 with 25 mM Hepes and 1.0 nM insulin at 378C, pH 7.4 for 1 h. Explants were then blotted
and transferred to a fresh medium comprising medium 199 with 25 mM Hepes and 1.0 nM insulin, pH 7.4 and incubated for either 2 or 8 h at 378C. Adipose tissue
explants were then blotted and frozen in liquid N2 for later RNA extraction and subsequent real-time PCR for 18S and TNFa amplicons. (a) mRNA abundance for
the genes of interest at 2 h after treatment with BSA or MCD. (b) mRNA abundance for the genes of interest at 8 h after ending treatment with BSA or MCD. The
relative expression of the genes of interest, standardized against the amount of 18S mRNA, was calculated using the DDCT method. Data are expressed as the
percent of relative abundance of the gene of interest to 18S in the control adipose explants as calculated with the (0% albumin/0% MCD). BSA5 low endotoxin
BSA (,1.0 ng/mg); MCD5methyl-b-cyclodextrin. abcdMeans not sharing a common superscript letter are different (P, 0.05).
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whereas an increase in IL6 gene expression was detected
with 0.05% MCD in the medium and IL6 expression
increased up to 25-fold with 0.2% MCD in the treatment
medium (P, 0.019; Figure 1a). An 8-h incubation following
the initial 1 h MCD treatment resulted in a much higher
increase in IL6 mRNA abundance than the 2-h incubation
(Figure 1b). Treatment with 0.05% MCD resulted in a 36-fold
increase in IL6 mRNA abundance, whereas 0.2% MCD
produced a 100-fold increase in IL6 gene expression relative
to the control incubated with basal medium. The BSA
treatment again had no detectable effect on IL6 mRNA
abundance (P. 0.05).
Analysis of the mRNA abundance for enzymes that are rate
limiting for lipogenesis demonstrated that neither ACAC nor
FASN were affected within 2 h of exposure to BSA or MCD
(P. 0.05; Figure 1a, respectively). Incubation for 8 h following
removal of the BSA or MCD treatment resulted in a decline in
ACAC mRNA abundance with 0.1% BSA or 0.05% MCD in the
medium (P, 0.001; Figure 1b). No further change in ACAC
gene expression occurred with higher concentrations of BSA
than 0.1% (P. 0.05); however increasing the concentration of
MCD to 0.2% led to a further 70% suppression in ACAC mRNA
abundance (P, 0.001). Similarly, treatment with 0.1% or
higher concentrations of MCD subsequently reduced FASN
mRNA abundance (P, 0.008; Figure 1b).
Incubation with 14C-glucose for 2 h, following a 1-h
exposure to BSA or MCD, demonstrated that neither treat-
ment affected basal or insulin-stimulated glucose oxidation
at that time point (Figure 2a). However, incubation for 8 h
(with inclusion of 14C glucose during the last 2 h) following
0.2% BSA or 0.2% MCD treatment demonstrated that
MCD could limit the insulin response relative to the BSA
treatment. Exposure of tissue explants to insulin following
BSA treatment resulted in more than a fourfold increase in
glucose oxidation, whereas MCD treatment resulted in less
than a threefold increase in glucose oxidation with insulin
treatment (P, 0.009).
Lipogenic rates were also affected by MCD treatment
(Figure 2b). Insulin-stimulated glucose incorporation into
fatty acids by ,180%, following exposure to 0.2% BSA in
the 2-h incubation (P, 0.01), whereas MCD inhibited the
development of an insulin response in adipose tissue
explants (P. 0.05). The insulin response by BSA-treated
tissue was much greater at 8 h than at 2 h with approxi-
mately a sixfold increase in fatty acid synthesis (P, 0.001).
In contrast, MCD treatment resulted in limiting insulin
stimulation of basal glucose incorporation into fatty acids to
,150% (P, 0.01). Neither BSA nor MCD affected basal
oxidation or lipogenesis (P. 0.05).
Incubation with 10mg of a monoclonal TNF antibody did
not alter insulin-stimulated glucose oxidation or lipogenesis,
following treatment with 0.2% BSA at either 2 or 8 h (Figure 3).
2 Hr 8 Hr0
50
100
150
200
250
300
350
400
450
500
550
600
R
el
at
iv
e 
G
lu
co
se
 O
xid
at
io
n
BSA BSA + Ins MCD MCD+Ins
a
abc
ab
a a
d
c
abc
2 Hr 8 Hr
0
100
200
300
400
500
600
700
800
R
el
at
iv
e 
Li
po
ge
ne
sis
BSA BSA + Ins MCD MCD+Ins
a
c
ab b ab a
d
c
Figure 2 Glucose metabolism in response to treatment with albumin or MCD. 14C-glucose oxidation and incorporation into lipid was performed, according to
procedures described in the Methodology. Following 0.2% MCD or 0.2% BSA treatments for 1 h, tissue explants were transferred to 25 ml Erlenmeyer flasks
with a medium containing 0.05% BSA6 100 nM insulin and 0.5mCi (U)-14C-glucose. Glucose metabolism was then monitored for 2 h with subsequent
collection of 14CO2 and extraction of
14C-labeled lipids from the tissue explants. Alternatively, MCD- and BSA-treated explants were placed in a basal medium
(medium 199, 25 mM HEPES, 10 mm glucose, 0.05% BSA, 1 nM insulin) for 6 h before transferring to Erlenmeyer flasks for the 2-h 14C-glucose incubation
(a total of 8 h after MCD treatment). (a) Glucose oxidation at 2 and 8 h. (b) Lipogenesis from glucose at 2 and 8 h after MCD or BSA treatment. Each metabolic
experiment was repeated three times with explants derived from three separate pigs and using triplicate explants/treatment for each pig. Data are expressed
as a relative % of metabolic activity of explants incubated in medium without BSA or MCD. BSA5 low-endotoxin BSA (,1.0 ng/mg); MCD5methyl-b-
cyclodextrin; Ins5 100 nM porcine insulin. abcd Means not sharing a common superscript letter are different (P, 0.05).
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Figure 3 Effect of addition of an anti-TNF monoclonal antibody on insulin-
stimulated glucose metabolism. 14C-glucose oxidation and incorporation
into lipid was performed, according to procedures described in the
Methodology. Following 0.2% MCD or 0.2% BSA treatments for 1 h, tissue
explants were transferred to 25 ml Erlenmeyer flasks with a medium
containing 0.05% BSA1 100 nM insulin and 0.5mCi (U)-14C-glucose6
10mg anti-pig TNF monoclonal antibody. Glucose metabolism was then
monitored for 2 h with subsequent collection of 14CO2 and extraction of
14C-labeled lipids from the tissue explants. Alternatively, MCD- and BSA-
treated explants were placed in medium 199 containing 25 mM HEPES,
10 mm glucose, 0.05% BSA, 1.0 nM insulin, with or without 10mg anti-pig
TNF monoclonal antibody for 6 h before transferring to Erlenmeyer flasks
for the 2-h 14C-glucose incubation6 10mg anti-pig TNF monoclonal
antibody (a total of 8 h after MCD treatment). Data are expressed as a
relative % change in oxidation or lipogenesis relative to explants incubated
in medium without antibody. *5Different from explants not treated with
the anti-pig TNF antibody (n5 3; P, 0.05). BSA5 low-endotoxin BSA
(,1.0 ng/mg); MCD5methyl-b-cyclodextrin; I5 100 nM porcine insulin.
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There was also no effect of the antibody on the metabolism
of tissue explants treated with 0.2% MCD for 2 h. However,
co-incubation of the TNF antibody in the medium for 8 h,
following treatment with 0.2% MCD, increased the insulin-
stimulated glucose oxidation by 26% (P, 0.05) and the
lipogenic rate by 35% (P, 0.05). Treatment with an IL6
antibody had no effect on any metabolic parameters
(P. 0.05; data not presented).
Discussion
Treatment of adipose tissue explants with MCD resulted in
an acute increase in TNF mRNA abundance. These experi-
ments were purposefully performed with adipose tissue
explants to preclude confounding the data with the use of
isolated adipocytes, because the process of adipocyte isola-
tion may also increase TNF expression (Ruan et al., 2003).
The observed increase in TNF mRNA abundance was in the
same range as reported by Le Lay et al. (2001), although the
present results were obtained within 2 h of MCD treatment
and had dissipated by 8 h. This was followed later by a large
surge in IL6 gene expression, much greater than reported
in 3T3-L1 adipocytes treated with a cholesterol synthesis
inhibitor (Le Lay et al., 2001). This may partially be accounted
for in the present study because measurements were made
within the first 24 h of treatment, whereas gene expression
was not analyzed until after 4 days of treatment in the
study with 3T3-L1 cells (Le Lay et al., 2001). Tumor necrosis
factor a can stimulate the expression of IL6 (Fasshauer et al.,
2003), which may account for some of the increase in IL6
mRNA abundance, following the increase in TNF gene
expression. Conversely, IL6 has been shown to inhibit TNF
protein expression (Starkie et al., 2003). An increase in IL6
protein in association with the rise in IL6 gene expression in
the present study would inhibit TNF gene transcription and
could contribute to the absence of any effect of MCD on TNF
mRNA abundance 8 h following treatment, but this requires
further research.
These changes in adipokine gene expression were asso-
ciated with a reduction in ACAC and FASN mRNA abundance
within 8 h of treatment with MCD. Tumor necrosis factor a
has been demonstrated to inhibit ACAC transcription in
the 30A-5 adipocyte cell line (Pape and Kim, 1988) and the
3T3-442A adipocyte cell line (Doerrler et al., 1994), whereas
FASN gene expression was demonstrated to be inhibited
by TNF in the 3T3-442A adipocytes (Doerrler et al., 1994).
In contrast, IL6 has not been reported to alter ACAC expression
or FASN expression in adipose tissue. However, IL6 has been
demonstrated to reduce lipogenesis in 3T3-L1 adipocytes in
association with a reduction in glucose transport (Lagathu
et al., 2003).
The decline in ACAC and FASN mRNA abundance with
MCD treatment in the present study suggested that lipo-
genesis is altered by MCD treatment. This was confirmed by
measuring 14C-glucose incorporation into fatty acids. The
data indicate that only insulin–stimulated, and not basal
lipogenesis, was affected by MCD treatment. Previous research
has only assessed and reported an effect on glucose oxidation
by isolated adipocytes (Le Lay et al., 2001), and this was also
observed in the present study with tissue explants.
The acknowledged mechanism of action for MCD is to
reduce cholesterol content of the plasma membrane; MCD
causes the collapse of caveolae in the plasma membrane by
the removal of cholesterol (Breen et al., 2012). The role of
caveolae may be quite important to the physiology and
metabolism of the adipocyte, as they can constitute up to
50% of the plasma membrane surface area of the adipocyte
(Thorn et al., 2003). The insulin receptor and insulin receptor
substrate-I (IRS-1) are two signaling proteins that are
localized to the cholesterol-rich caveolae in human adipo-
cytes (Karlsson et al., 2004), whereas only the insulin
receptor is localized in rat adipocytes (Parpal et al., 2001).
Treatment of human adipocytes with b-cyclodextrin (10 mM)
resulted in a reduction in membrane cholesterol content and
a reduction in glucose transport, although insulin receptor
phosphorylation and IRS-1phosphorylation were unaffected
(Karlsson et al., 2004). Treatment of rat adipocytes with a
similar concentration of b-cyclodextrin resulted in a reduc-
tion in membrane cholesterol content and reductions in
glucose transport and IRS-1 phosphorylation by insulin
(Parpal et al., 2001). These results are in agreement with Le
Lay et al. (2001), demonstrating the development of an
insulin resistance following 1.0 mM MCD treatment. The
present study using pig adipose tissue explants also
observed a reduction in insulin-stimulated glucose oxidation
and lipogenesis, following treatment with MCD relative to
albumin at 8 h following the treatment. At 2 h after MCD
treatment, only an effect on lipogenesis was detected,
although the insulin response by glucose oxidation following
MCD treatment was 28% less than after BSA treatment
(P. 0.05). The results at 8 h are intriguing, because this is
the timeframe following the elevation in TNF gene expression
and parallels the large increase in IL6 gene expression.
This raised the question as to whether these adipokines
may be contributing to the relative insulin resistance in
glucose metabolism at 8 h. Treatment with an anti-pig TNF
antibody resulted in reducing the resistance of glucose
metabolism to insulin, but only at 8 h after treatment; the
antibodies to IL6 did not alter the insulin resistance (data not
presented). Inclusion of the antibodies throughout the 8 h
permitted binding of preformed or tissue surface TNF, as well
as subsequently the synthesized and secreted TNF. These
data suggest that the induction of TNF following MCD
treatment contributed to the insulin resistance detected 8 h
after the treatment ended.
How MCD stimulates the expression and release of TNF is
not clear. The use of cyclodextrins to extract cholesterol from
caveolae is not a subtle method. Numerous receptors and
signaling molecules are affected, disturbed or recycled as a
result of the process. Therefore, the potential signal for this
increase in adipokine gene expression cannot be ascertained
at this time. What is abundantly clear is that MCD metaboli-
cally stresses the cell, resulting in an increase in TNF
expression that can have an impact on insulin sensitivity and
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thus glucose metabolism. A major purpose of this experiment
was to find a replacement for albumin, as it has shown to
induce cytokine expression by rat adipose tissue (Schlesinger
et al., 2006). However, the present study has demonstrated
that MCD is not a satisfactory substitute for albumin in
experiments to assess adipose-derived cytokines. A search for
a more appropriate substitute for albumin is still necessary.
In vivo, infusion of solutions containing 5% porcine albumin
caused anaphylaxis, whereas a 5% solution of MCD did not
(Wray-Cahen et al., 2001). The lack of an anaphylactic
response to MCD in that study would suggest that adipose-
derived cytokines may not make a significant contribution to
the overall peripheral response to MCD when assessed relative
to the observed acute elevation in TNF in the present study.
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